Hypermarcas (OTCMKTS:HYPMY) Trading Down 5.7% – Here’s Why

Shares of Hypermarcas (OTCMKTS:HYPMY) dropped 5.7% during trading on Monday . The stock traded as low as $3.96 and last traded at $3.96. Approximately 59,253 shares were traded during mid-day trading, an increase of 140% from the average daily volume of 24,652 shares. The stock had previously closed at $4.20.

Wall Street Analysts Forecast Growth

Separately, Zacks Research raised Hypermarcas to a “hold” rating in a research note on Wednesday, April 29th. One analyst has rated the stock with a Strong Buy rating and one has issued a Hold rating to the company’s stock. According to MarketBeat, the stock has a consensus rating of “Buy”.

Hypermarcas Stock Performance

The company has a market capitalization of $2.79 billion, a PE ratio of 8.27 and a beta of 0.70. The company has a debt-to-equity ratio of 0.61, a quick ratio of 0.84 and a current ratio of 1.27. The stock’s 50-day simple moving average is $4.52 and its 200 day simple moving average is $4.48.

Hypermarcas (OTCMKTS:HYPMY) last released its quarterly earnings data on Wednesday, April 29th. The company reported $0.10 earnings per share for the quarter. Hypermarcas had a net margin of 19.41% and a return on equity of 14.08%. The company had revenue of $383.13 million for the quarter. As a group, research analysts expect that Hypermarcas will post 0.53 earnings per share for the current fiscal year.

Hypermarcas Company Profile

Hypermarcas SA is a Brazil-based consumer health and pharmaceutical company whose shares trade over the counter in the United States under the symbol HYPMY. Founded in the early 2000s and headquartered in Rio de Janeiro, the company operates as a holding group for a broad portfolio of branded products in the healthcare and personal care sectors.

Through its various subsidiaries, Hypermarcas develops, manufactures and markets prescription and over-the-counter medications, alongside personal care, baby care, home care and nutritional supplement products.